ZetrOZ Systems, creator and manufacturer of the sam wearable ultrasound device product line, introduces its newest innovation, the samx1. The samx1 delivers high-quality, effective soft tissue and injury healing capabilities at home. A video of the device’s performance and features is available here.

“We intentionally and thoughtfully designed the samx1 with ergonomics in mind to deliver the same soft tissue healing for pain and injury in wireless form,” said Dr. George Lewis, founder and CEO of ZetrOZ Systems. “The samx1 is poised to make a difference in the lives of hundreds of thousands of patients dealing with soft tissue injuries.” 

Designed for ergonomics and ultrasound delivery to increase circulation and promote soft tissue healing, sam®x1 delivers 33 times more energy than a bone-growth stimulator after just one hour of treatment. Additional research shows: 

  • Medical staff have 87% satisfaction and increased confidence in sam to accelerate the healing process from overuse injuries (Draper et al., 2021)
  • sam treatment provides tissue healing and recovery, improved patient function, and reduced pain. When patients failed to respond to physical therapy, sam proved to be a useful adjunct to facilitate healing and return to work (Winkler et al., 2021)
  • sam provided clinical patient improvement in under two weeks of treatment and a 50% reduction of pain medication (Walters et al., 2022, clinical presentation)
  • 87.3% of athletes are highly receptive to treatment and have a high level of confidence for improved function and return to work after 30 days of sam use (Walters et al., 2022, clinical presentation)

For treating acute and chronic musculoskeletal conditions, samx1 is an effective tool for decreased pain, increased movement and blood circulation, and improved quality of life. 

The sam gel capture patch creates the ideal connection and fit for healing. The wireless capability allows sam to attach securely and discreetly, balancing for weight but allowing patients to participate in aggressive activity. A rugged storage case, including two rapid chargers, a quick start guide, and a user manual, offers on-the-go usage.

“Backed by thousands of successful patient outcomes, samx1 is shifting the paradigm in the care of soft tissue injuries, and we are excited to see doctors and physicians utilize this treatment to better the lives of their patients,” concluded Dr. Lewis.

After over a decade of development, samx1 from ZetrOZ Systems is the first wireless long-duration ultrasound system that is FDA-cleared for prescription home use. samx1 is made in the USA and covered by 48 patents. 

[Source(s): ZetrOZ, GlobeNewswire]

Related Content:
ZetrOZ Systems Expands Clinical Education on Sustained Acoustic Medicine